GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jushi Holdings Inc (OTCPK:JUSHF) » Definitions » Capex-to-Revenue

Jushi Holdings (Jushi Holdings) Capex-to-Revenue : 0.02 (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Jushi Holdings Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Jushi Holdings's Capital Expenditure for the three months ended in Mar. 2024 was $-1.08 Mil. Its Revenue for the three months ended in Mar. 2024 was $65.46 Mil.

Hence, Jushi Holdings's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.02.


Jushi Holdings Capex-to-Revenue Historical Data

The historical data trend for Jushi Holdings's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jushi Holdings Capex-to-Revenue Chart

Jushi Holdings Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.28 0.36 0.20 0.04

Jushi Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.02 0.03 0.04 0.02

Competitive Comparison of Jushi Holdings's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Jushi Holdings's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jushi Holdings's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jushi Holdings's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Jushi Holdings's Capex-to-Revenue falls into.



Jushi Holdings Capex-to-Revenue Calculation

Jushi Holdings's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-10.743) / 269.445
=0.04

Jushi Holdings's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-1.077) / 65.459
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jushi Holdings  (OTCPK:JUSHF) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Jushi Holdings Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Jushi Holdings's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Jushi Holdings (Jushi Holdings) Business Description

Traded in Other Exchanges
Address
301 Yamato Road, Suite 3250, Boca Raton, FL, USA, 33431
Jushi Holdings Inc is a vertically integrated multi-state cannabis and hemp operator across the United States. The company operates a diverse portfolio of branded cannabis and hemp-derived assets, built upon opportunistic acquisitions, distressed deals and competitive applications. Operating under the Jushi umbrella is the BEYOND / HELLO retail brand of cannabis dispensaries, hemp-based CBD brand, Nira, including its brands, The Lab: Concentrates and The Bank: Flower + Genetics, as well as its precision formulated line of medical cannabis products Nira Plus. Jushi strives to maximize shareholder value while delivering high premium products across all levels of the cannabis and hemp ecosystem.